Trial intelligence / Profile preview

Sitagliptin for Post-Cardiac Surgery Hyperglycemia

NCT01970462Phase 4Terminated

Start
Jan 2014
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in Stress Hyperglycemia (SH), type 2 diabetes mellitus (T2DM). Started Jan 2014; status: terminated.

02

Drugs

sitagliptin
03

Conditions

Stress Hyperglycemia (SH)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01970462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01970462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call